Phibro Animal Health (PAHC) Accumulated Expenses (2013 - 2026)
Phibro Animal Health (PAHC) posted Accumulated Expenses of $164.1 million for Q2 2026, up 26.84% on a QoQ basis from $129.4 million in Q1 2026, and up 18.06% year-over-year from $139.0 million in Q2 2025.
Analysis
Phibro Animal Health (PAHC) Accumulated Expenses (2013 - 2026) Analysis & Trends
Phibro Animal Health has reported Accumulated Expenses for 14 years, with the latest figure at $164.1 million in Q2 2026.
- On a quarterly basis, Accumulated Expenses rose 18.06% year-over-year to $164.1 million in Q2 2026; TTM through Jun 2026 was $164.1 million, a 18.06% increase from a year earlier, with the FY2026 full-year figure at $164.1 million, up 18.06% from the prior year.
- Accumulated Expenses was $164.1 million for Q2 2026 at Phibro Animal Health, up from $129.4 million in the prior quarter.
- The five-year high for Accumulated Expenses was $164.1 million in Q2 2026, with the low at $68.7 million in Q3 2022.
- Average Accumulated Expenses over 5 years is $98.3 million, with a median of $82.6 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Accumulated Expenses decreased 10.06% in 2023, then soared 56.58% in 2025.
- Over 5 years, Accumulated Expenses stood at $71.7 million in 2022, then gained by 5.05% to $75.3 million in 2023, then soared by 56.16% to $117.6 million in 2024, then grew by 9.26% to $128.4 million in 2025, then increased by 27.79% to $164.1 million in 2026.
- The last three Accumulated Expenses figures came in at $164.1 million (Q2 2026), $129.4 million (Q1 2026), and $128.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 164.13 Mn |
| Mar 31, 2026 | 129.40 Mn |
| Dec 31, 2025 | 128.44 Mn |
| Sep 30, 2025 | 121.10 Mn |
| Jun 30, 2025 | 139.02 Mn |
| Mar 31, 2025 | 118.61 Mn |
| Dec 31, 2024 | 117.56 Mn |
| Sep 30, 2024 | 82.87 Mn |
| Jun 30, 2024 | 88.79 Mn |
| Mar 31, 2024 | 76.65 Mn |
| Dec 31, 2023 | 75.28 Mn |
| Sep 30, 2023 | 70.99 Mn |
| Jun 30, 2023 | 79.85 Mn |
| Mar 31, 2023 | 74.12 Mn |
| Dec 31, 2022 | 71.66 Mn |
| Sep 30, 2022 | 68.70 Mn |
| Jun 30, 2022 | 80.24 Mn |
| Mar 31, 2022 | 82.41 Mn |
| Dec 31, 2021 | 72.84 Mn |
| Sep 30, 2021 | 74.53 Mn |